GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+40mg+500mg)
B. Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+80mg+500mg)
C. Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+40mg+500mg)
Each uncoated Bilayered tablet contains:
Voglibose IP………………………………………0.2mg
Gliclazide IP………………………………………40mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Excipients………………………………………q.s
Colour: Ponceau 4R Lake

B) Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.2mg+80mg+500mg)
Each uncoated Bilayered tablet contains:
Voglibose IP………………………………………0.2mg
Gliclazide IP………………………………………80mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Excipients………………………………………q.s
Colour: Sunset Yellow FCF

C) Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg)
Each uncoated Bilayered tablet contains:
Voglibose IP………………………………………0.3mg
Gliclazide IP………………………………………80mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Excipients………………………………………q.s
Colour: Quinoline Yellow WS

THERAPEUTIC INDICATIONS:

GLICLAZIDE+METFORMIN+VOGLIBOSE belongs to a class of medicine known as an antidiabetic primarily indicated in the treatment of type 2 diabetes mellitus. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose.

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.

SCHEDULE G PRESCRIPTION DRUG-CAUTION: It is dangerous to take the prescription except under medical supervision.

SCHEDULE H PRESCRIPTION DRUG-WARNING: To be sold by retail on the prescription of a registered medical practitioner only.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.

Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg) Technical Specification:

Product Name: Voglibose + Gliclazide + Metformin Hydrochloride Tablets
Brand Name: Generic
Strength: (0.2mg+40mg+500mg),   (0.2mg+80mg+500mg),   (0.3mg+80mg+500mg)
Dosage Form: Tablets (uncoated)
Route of Administration: Via Oral Route
Packing: 10 strips of 10 tablets each
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Regulatory Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Antidiabetic
Indication: GLICLAZIDE+METFORMIN+VOGLIBOSE belongs to a class of medicine known as an antidiabetic primarily indicated in the treatment of type 2 diabetes mellitus. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose.
Storage: Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg)

 QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg)
    Each uncoated Bilayered tablet contains:
    Voglibose IP………………………………………0.3mg
    Gliclazide IP………………………………………80mg
    Metformin Hydrochloride IP…………………….500mg
    (As Sustained Release Form)
    Excipients………………………………………q.s
    Colour: Quinoline Yellow WS

THERAPEUTIC INDICATIONS:

GLICLAZIDE+METFORMIN+VOGLIBOSE belongs to a class of medicine known as an antidiabetic primarily indicated in the treatment of type 2 diabetes mellitus. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose.

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
 Tablet to be swallowed as a whole, and not to be chewed or crushed.

SCHEDULE G PRESCRIPTION DRUG-CAUTION: It is dangerous to take the prescription except under medical supervision.

SCHEDULE H PRESCRIPTION DRUG-WARNING: To be sold by retail on the prescription of a registered medical practitioner only. 

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.

Introduction to Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg)

The combination of Voglibose (0.3mg), Gliclazide (80mg), and Metformin HCl (500mg) is a powerful, synergistic therapy for the management of Type 2 diabetes mellitus, especially for patients who require comprehensive glycemic control.

What the Triple Combination Contains:

  • Voglibose (0.3mg): An alpha-glucosidase inhibitor that prevents post-meal sugar spikes by slowing glucose absorption.

  • Gliclazide (80mg): A sulfonylurea that increases insulin secretion from pancreatic beta cells.

  • Metformin Hydrochloride (500mg): Improves insulin sensitivity and reduces glucose production from the liver.


Medical Uses

This triple combination is highly effective in:

✔ Reducing HbA1c levels
✔ Managing fasting and postprandial blood glucose
✔ Preventing diabetes-related complications
✔ Improving long-term metabolic health

Taj Pharma, the well-known Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg) Manufacturer in India, ensures each tablet is produced with precision, high purity, and therapeutic consistency.

Dosage & Administration

According to medical guidance:

  • Should be taken with meals

  • Must be consumed regularly at the same time daily

  • Dosage must follow the doctor’s prescription based on blood sugar levels

Global Demand

The demand for triple-combination diabetes drugs is rising across:

  • Latin America

  • Africa

  • Middle East

  • South-East Asia

  • CIS countries

As governments and healthcare systems increasingly adopt cost-effective diabetes solutions, Taj Pharma plays a vital role by supplying high-quality medicines at globally competitive prices.


In-depth Details for Importers, Exporters, and Global Buyers

Taj Pharma is recognized worldwide for its ability to meet stringent regulatory expectations, large-volume orders, and long-term contract manufacturing.


 Regulatory Documentation Provided by Taj Pharma

To support smooth market entry and registration, Taj Pharma provides:

  • WHO-GMP Certificate

  • COPP (Certificate of Pharmaceutical Product)

  • Valid Manufacturing License

  • COA (Certificate of Analysis – Batch wise)

  • MSDS (Material Safety Data Sheet)

  • CTD/ACTD Dossier

  • Free Sale Certificate

  • Stability Studies (Zone II & IV)

  • GMP Certificate

  • Packaging and Labeling SOPs

This exhaustive documentation makes the registration process easier in both emerging and regulated markets.


Custom Packaging & International Labeling Support

Taj Pharma offers complete customization for global pharma buyers:

  • Blister / Alu-Alu / Strip packaging

  • 10×10 or 10×15 blister formats

  • Country-specific labeling compliance

  • Multilingual packaging (French/Spanish/Arabic)

  • Buyer branding (OEM / private labeling)


Shelf-Life, Storage & Dosage Form

  • Dosage Form: Oral Tablet

  • Strength: 0.3mg + 80mg + 500mg

  • Shelf Life: 24–36 months

  • Storage: Keep below 25°C, protect from moisture and sunlight

  • Presentation: Tablet in blisters/cartons


Export Certifications

Taj Pharma adheres to globally accepted manufacturing and quality systems:

  • WHO-GMP

  • EU-GMP (compliant systems)

  • ISO 9001:2015

  • Regulatory-approved COA

  • CTD/ACTD Dossiers

  • GMP-compliant documentation

This makes Taj Pharma one of the most dependable exporters of Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg) worldwide.


Target Countries & Export Markets

Taj Pharma exports this triple-combination diabetes medication to:

USA, UK, South Africa, Kenya, Nigeria, Ghana, Vietnam, Myanmar, Philippines, Bangladesh, Sri Lanka, Iraq, Yemen, Uzbekistan, Kazakhstan, Georgia, Peru, Bolivia, Ukraine, Cambodia

These regions have seen rapid adoption of Taj Pharma products due to their reliability and affordability.


 Why Taj Pharma is the Most Trusted Manufacturer & Exporter of Diabetes Combination Tablets

 1. State-of-the-Art WHO-GMP Manufacturing

Taj Pharma’s production facilities include:

  • Automated tableting & compression systems

  • High-precision granulation lines

  • International quality-compliant cleanrooms

  • Robust quality control laboratories

  • In-house stability chambers

Every batch undergoes strict quality testing before release.


  2. Affordable Pricing & Highest Purity Standards

Taj Pharma ensures:

  • Competitive export pricing

  • High-purity API procurement

  • In-process quality checks

  • Impurity profiling

  • Dissolution and assay tests

Buyers get world-class quality at the best pricing, making Taj Pharma ideal for government tenders and bulk requirements.


 3. Global Supply Chain Strength

With large-scale distribution networks and logistics support, Taj Pharma delivers:

  • Swift shipping

  • Temperature-controlled warehousing

  • End-to-end supply chain assistance

  • Export documentation support


 4. Top 20 Countries 

Nigeria | Kenya | Ghana | Tanzania | Uganda | Myanmar | Vietnam | Philippines | Yemen | Afghanistan | Iraq | Iran | Peru | Bolivia | Chile | Mexico | Dominican Republic | Nepal | Cambodia |Ethiopia

Technical Product Specification Table

Parameter Details
Product Name Voglibose + Gliclazide + Metformin Hydrochloride Tablets
Strength 0.3mg + 80mg + 500mg
Manufacturer Taj Pharma India
Indication Type 2 Diabetes Mellitus
Dosage Form Oral Tablet
Packaging Alu-Alu / Blister
Shelf Life 24–36 months
Certification WHO-GMP, ISO, COA, COPP
Storage Below 25°C

Call to Action

If you are a pharmaceutical distributor, importer, or PCD franchise seeker searching for a trusted, globally recognized manufacturer of Voglibose + Gliclazide + Metformin Hydrochloride Tablets (0.3mg+80mg+500mg), Taj Pharma is your best choice.

✔ Contact Taj Pharma for:

  • Bulk production

  • PCD Pharma Franchise

  • Tender supply

  • Private label manufacturing

  • International product registration

Website: www.tajpharma.com
Email:  info@tajpharma.com
Location: Vapi, Gujarat, India


Top 20 FAQs 

1. What is this triple combination used for?

It is used for effective management of Type 2 diabetes.

2. Is Taj Pharma a WHO-GMP certified manufacturer?

Yes, Taj Pharma is WHO-GMP and ISO certified.

3. When should this medicine be taken?

Preferably with meals, as prescribed by a doctor.

4. Are the tablets safe for long-term use?

Yes, under medical supervision.

5. Do you provide CTD/ACTD dossiers for export?

Yes, complete dossiers are available.

6. What are the common side effects?

Hypoglycemia, nausea, stomach pain, headache, and dizziness.

7. Can this medicine cause low blood sugar?

Yes—patients must carry sugar or juice to manage hypoglycemia.

8. Does Taj Pharma offer private branding?

Yes, OEM / private label available.

9. What is the typical shelf life?

24–36 months.

10. Is international export available?

Yes, supplied to 40+ countries.

11. What packaging options exist?

Blister, strip, and Alu-Alu.

12. Do you support tender requirements?

Absolutely.

13. Can I request product samples?

Yes, samples can be provided for registration.

14. Is this medicine suitable for large-scale procurement?

Yes, production capacity supports high-volume orders.

15. What export documents do you provide?

COPP, FSC, COA, MSDS, CTD dossier, etc.

16. Does Taj Pharma comply with pharmacopeia standards?

Yes, IP/USP/EP as per requirement.

17. Do you ship worldwide?

Yes, with reliable logistics partners.

18. Is PCD franchise available?

Yes, PAN India PCD options exist.

19. Does this medicine require a prescription?

Yes, as it controls blood glucose.

20. Why should I choose Taj Pharma?

Quality, compliance, affordability, and global reliability.